Roche · 9 hours ago
2026 Summer Intern - Data Science Acceleration
Roche is a leading biotechnology company committed to advancing science and healthcare. The Data Scientist intern in the Data Science Acceleration team will develop scalable tools and workflows for efficient statistical computing, collaborating closely with other professionals to streamline evidence generation and decision-making.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Develop experience in statistical analysis of clinical trial data
Develop AI agents to address specific business problems
Learn about the role of data sciences in drug development
Qualification
Required
Must be pursuing a Master's Degree (enrolled student)
Must have attained a Master's Degree
Must be pursuing a PhD (enrolled student)
Must have attained a PhD
Required Majors: Computer Science, Data Science, Statistics, BioInformatics, Engineering or a related quantitative discipline
Proficient in programming languages commonly used in statistical computing (e.g., R, Python) and are familiar with development tools such as Git, Docker, or workflow automation tools
Solid understanding of clinical trial data structures, statistical analysis concepts, or biomedical data (e.g., omics, real-world data, operational data)
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
2026-01-23
2026-01-22
Company data provided by crunchbase